DIFFERENT SECRETION PATTERNS OF ATRIAL-NATRIURETIC-PEPTIDE AND BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:594
作者
YOSHIMURA, M
YASUE, H
OKUMURA, K
OGAWA, H
JOUGASAKI, M
MUKOYAMA, M
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CARDIOMYOPATHY; DILATED; MITRAL STENOSIS;
D O I
10.1161/01.CIR.87.2.464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are increased in relation to the severity of congestive heart failure (CHF). This study was designed to examine whether the secretion patterns of ANP and BNP vary with underlying cardiac disorders of CHF with different degrees of overload in atria and ventricles. Methods and Results. We measured plasma levels of ANP and BNP in the aorta in 20 patients with mitral stenosis (MS) in whom atria are mainly overloaded, 30 patients with dilated cardiomyopathy (DCM) in whom both atria and ventricles are overloaded, and 20 control subjects during cardiac catheterization. Pulmonary capillary wedge pressure (PCWP) was significantly higher in the MS and DCM groups (16.7+/-4.7 mm Hg and 15.1+/-7.7 mm Hg, respectively) than in the control group (7.2+/-1.1 mm Hg, p<0.01), whereas there was no significant difference between the MS and DCM groups. Left ventricular end-diastolic pressure (LVEDP) was significantly higher in the DCM group than in the MS group (16.4+/-7.8 mm Hg versus 7.6+/-2.0 mm Hg, p<0.01), and the level was comparable between the MS and control groups (7.6+/-2.0 mm Hg versus 6.8+/-1.2 mm Hg, p=NS). The plasma ANP level was significantly higher in the MS and DCM groups (356+/-169 pg/ml and 331+/-323 pg/ml, respectively) than in the control group (98+/-41 pg/ml, p<0.01), whereas there was no significant difference between the MS and DCM groups. The plasma BNP level was significantly higher in the DCM group than in the MS group (333+/-405 pg/ml versus 147+/-54 pg/ml, p<0.01), and the level was significantly higher in the MS group than in the control group (147+/-54 pg/ml versus <10 pg/ml,p<0.01). The plasma levels of ANP and BNP had a highly positive correlation with PCWP in the DCM group (p<0.01). On the other hand, in the MS group, the plasma ANP level had a highly significant correlation with PCWP (p<0.01) but the plasma BNP level did not. Conclusions. We conclude that plasma levels of BNP mainly reflect the degree of ventricular overload and that the secretion patterns of ANP and BNP vary with underlying cardiac disorders of CHF with different degrees of overload in atria and ventricles.
引用
收藏
页码:464 / 469
页数:6
相关论文
共 37 条
  • [1] ROLE OF ATRIAL PEPTIDES IN BODY-FLUID HOMEOSTASIS
    BALLERMANN, BJ
    BRENNER, BM
    [J]. CIRCULATION RESEARCH, 1986, 58 (05) : 619 - 630
  • [2] ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN
    BURNETT, JC
    KAO, PC
    HU, DC
    HESER, DW
    HEUBLEIN, D
    GRANGER, JP
    OPGENORTH, TJ
    REEDER, GS
    [J]. SCIENCE, 1986, 231 (4742) : 1145 - 1147
  • [3] ATRIAL-NATRIURETIC-FACTOR IN NORMAL SUBJECTS AND HEART-FAILURE PATIENTS - PLASMA-LEVELS AND RENAL, HORMONAL, AND HEMODYNAMIC-RESPONSES TO PEPTIDE INFUSION
    CODY, RJ
    ATLAS, SA
    LARAGH, JH
    KUBO, SH
    COVIT, AB
    RYMAN, KS
    SHAKNOVICH, A
    PONDOLFINO, K
    CLARK, M
    CAMARGO, MJF
    SCARBOROUGH, RM
    LEWICKI, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) : 1362 - 1374
  • [4] A RAPID AND POTENT NATRIURETIC RESPONSE TO INTRAVENOUS-INJECTION OF ATRIAL MYOCARDIAL EXTRACT IN RATS
    DEBOLD, AJ
    BORENSTEIN, HB
    VERESS, AT
    SONNENBERG, H
    [J]. LIFE SCIENCES, 1981, 28 (01) : 89 - 94
  • [5] IDENTIFICATION OF ATRIAL NATRIURETIC FACTOR WITHIN VENTRICULAR TISSUE IN HAMSTERS AND HUMANS WITH CONGESTIVE HEART-FAILURE
    EDWARDS, BS
    ACKERMANN, DM
    LEE, ME
    REEDER, GS
    WOLD, LE
    BURNETT, JC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) : 82 - 86
  • [6] EXPRESSION OF BRAIN NATRIURETIC PEPTIDE GENE IN HUMAN HEART - PRODUCTION IN THE VENTRICLE
    HOSODA, K
    NAKAO, K
    MUKOYAMA, M
    SAITO, Y
    JOUGASAKI, M
    SHIRAKAMI, G
    SUGA, S
    OGAWA, Y
    YASUE, H
    IMURA, H
    [J]. HYPERTENSION, 1991, 17 (06) : 1152 - 1156
  • [7] ANTIDIPSOGENIC ACTION OF A NOVEL PEPTIDE, BRAIN NATRIURETIC PEPTIDE, IN RATS
    ITOH, H
    NAKAO, K
    YAMADA, T
    SHIRAKAMI, G
    KANGAWA, K
    MINAMINO, N
    MATSUO, H
    IMURA, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 150 (1-2) : 193 - 196
  • [8] OCCURRENCE OF A NOVEL CARDIAC NATRIURETIC PEPTIDE IN RATS
    ITOH, H
    NAKAO, K
    KAMBAYASHI, Y
    HOSODA, K
    SAITO, Y
    YAMADA, T
    MUKOYAMA, M
    ARAI, H
    SHIRAKAMI, G
    SUGA, S
    YOSHIDA, I
    INOUYE, K
    IMURA, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) : 732 - 739
  • [9] BIOLOGICAL CHARACTERIZATION OF HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) AND RAT BNP - SPECIES-SPECIFIC ACTIONS OF BNP
    KAMBAYASHI, Y
    NAKAO, K
    KIMURA, H
    KAWABATA, T
    NAKAMURA, M
    INOUYE, K
    YOSHIDA, N
    IMURA, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (02) : 599 - 605
  • [10] ISOLATION AND SEQUENCE DETERMINATION OF HUMAN-BRAIN NATRIURETIC PEPTIDE IN HUMAN ATRIUM
    KAMBAYASHI, Y
    NAKAO, K
    MUKOYAMA, M
    SAITO, Y
    OGAWA, Y
    SHIONO, S
    INOUYE, K
    YOSHIDA, N
    IMURA, H
    [J]. FEBS LETTERS, 1990, 259 (02) : 341 - 345